News

Can Boston stay on top in biotech? Find out on Sept 17, 6-9 p.m. EDT to explore talent shifts, funding, and Boston’s future.
The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...
Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, Aug. 14, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: ...
The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.
Dividend stocks are a time-tested way to retire or protect your portfolio if you are already retired. Their yield can give ...
With federal public health agencies under the helm of Robert F. Kennedy Jr., a longtime vaccine critic, the usual schedule ...
Europe, Ukraine hope for chilly Putin summit ▪ The Hill interview: Newsom defends redistricting fight ▪ Progressives take center stage in mayoral contests ▪ Israel steps up ...
Patients with MASH and stage II or III fibrosis treated with ervogastat and clesacostat are more likely than those on placebo to achieve MASH resolution without fibrosis worsening.
Pfizer Inc. just made headlines by acquiring a promising biotech firm. The strategic move aims to enhance Pfizer's portfolio ...
Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.
Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.